Literature DB >> 3113331

Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland.

O V Renkonen, A Sivonen, R Visakorpi.   

Abstract

The efficacy of ciprofloxacin in eradicating pharyngeal colonization of Neisseria meningitidis was studied among army recruits in Finland. Ciprofloxacin (250 mg) or placebo was given twice a day for 2 days to 118 meningococcal carriers. Meningococcal carriage was eradicated in 96% of subjects given ciprofloxacin and in 13% of those given placebos.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3113331      PMCID： PMC284224          DOI： 10.1128/AAC.31.6.962

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Use of antiserum agar plates for serogrouping of meningococci.

Authors:  A Sivonen; O V Renkonen; J B Robbins
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

2.  Adverse effects of two rifampicin dosage regimens for the prevention of meningococcal infection.

Authors:  J D Band; D W Fraser
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

3.  Trends in meningococcal disease in the United States, 1975-1980.

Authors:  J D Band; M E Chamberland; T Platt; R E Weaver; C Thornsberry; D W Fraser
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

4.  An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations.

Authors:  I Salmi; O Pettay; I Simula; A K Kallio; O Waltimo
Journal:  Scand J Infect Dis       Date:  1976

5.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors:  A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  Neisseria meningitidis infections in Northern Norway: an epidemic in 1974-1975 due mainly to group B organisms.

Authors:  K Bovre; E Holten; H Vik-Mo; A Brondbo; D Bratlid; P Bjark; P J Moe
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

7.  The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland.

Authors:  A Sivonen; O V Renkonen; P Weckström; K Koskenvuo; V Raunio; P H Mäkelä
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

8.  Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.

Authors:  M A Gonzalez; F Uribe; S D Moisen; A P Fuster; A Selen; P G Welling; B Painter
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Comparative in vitro studies with 4-quinolone antimicrobials.

Authors:  D Felmingham; M D O'Hare; M J Robbins; R A Wall; A H Williams; A W Cremer; G L Ridgway; R N Grüneberg
Journal:  Drugs Exp Clin Res       Date:  1985
  9 in total
  15 in total

Review 1.  Infections diseases: meningococcal disease.

Authors:  C A Hart
Journal:  West J Med       Date:  2000-08

Review 2.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  [Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].

Authors:  P Nicolas; J D Cavallo; R Fabre; G Martet
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

5.  Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers.

Authors:  D L Dworzack; C C Sanders; E A Horowitz; J M Allais; M Sookpranee; W E Sanders; F M Ferraro
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

6.  Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.

Authors:  Ulla Jounio; Annika Saukkoriipi; Holly B Bratcher; Aini Bloigu; Raija Juvonen; Sylvi Silvennoinen-Kassinen; Ari Peitso; Terttu Harju; Olli Vainio; Markku Kuusi; Martin C J Maiden; Maija Leinonen; Helena Käyhty; Maija Toropainen
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

Review 7.  Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.

Authors: 
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

8.  Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis.

Authors:  O H Gilja; A Halstensen; A Digranes; H Mylvaganam; A Aksnes; E A Høiby
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.

Authors:  J M Blondeau; Y Yaschuk
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

10.  Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.

Authors:  T J Louie
Journal:  CMAJ       Date:  1994-03-01       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.